AN OVERVIEW OF INCRETIN-BASED THERAPIES: PHARMACOLOGY AND FUTURE PERSPECTIVES
Glucagon-like peptide-1 (GLP-1) is a gut-derived incretin hormone that is released upon nutrient ingestion stimulating insulin secretion, suppressing glucagon secretion, and suppressing appetite and food intake which contribute to glucose homeostasis. The incretin system is impaired during type 2 di...
محفوظ في:
| المؤلفون الرئيسيون: | , , , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
Assiut University, Faculty of Pharmacy
2022-12-01
|
| سلاسل: | Bulletin of Pharmaceutical Sciences. Assiut University |
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://bpsa.journals.ekb.eg/article_271789_26f9de42af59a6d1fe9a68a3b3d98fbf.pdf |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|